I'm not sure how MRK is going to differentiate themselves from GILD with this program - 12 week duration for naives, they will have to do a separate trial in nulls and cirrhotics to complete with ENTA and GILD I can see now why they felt the need to go out and pay big for an early stage nuke Unless they are keeping a DDI trial close to the vest the fact the IDIX purchased nuke hasn't progressed yet is also somewhat bullish for GILD and ENTA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.